3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
28
Gastrointestinal Stromal Tumors
4
Colonic Neoplasms
4
Carcinoma, Hepatocellular
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Neoplasms
3
Neoplasm Metastasis
3
Rectal Neoplasms
2
Gallbladder Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Bile Duct Neoplasms
2
Urothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer)
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Somatostatinoma
1
Sarcoma
1
Rhabdomyosarcoma
1
Renal Insufficiency
1
Physician Education
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Noonan Syndrome 6
1
Metastatic Pancreatic Adenocarcinoma
1
Melanoma
1
Liver Neoplasms
1
Liposarcoma
1
Insulinoma
1
Interventions
Temozolomide
30
Radiotherapy
21
Etoposide
9
Carboplatin
9
Bevacizumab
9
Cyclophosphamide
8
Vincristine
7
Radiation
7
Filgrastim
7
Cisplatin
7
Magnetic Resonance Spectroscopy
6
Irinotecan
5
Ifosfamide
5
Granulocyte Colony-Stimulating Factor
5
etoposide phosphate
4
X-Rays
4
Specimen Handling
4
Phantoms, Imaging
4
Lomustine
4
Everolimus
4
selpercatinib
3
larotrectinib
3
Thalidomide
3
Paclitaxel
3
Nuclear Medicine Department, Hospital
3
Methotrexate
3
Erlotinib Hydrochloride
3
Chemotherapy, Adjuvant
3
Celecoxib
3
Bortezomib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Central Nervous System Neoplasms
×
regorafenib
×
Clear all
No trials found.